Mónica Viveros-rogel - Infectious Diseases

Author Information

Mónica Viveros-rogel is affiliated with the Department of Infectious Diseases at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, located in Mexico City, Mexico. Her work primarily focuses on the study of HIV, exploring various aspects of the virus, including immune responses, viral inactivation, and drug resistance.

Research Contributions

Mónica Viveros-rogel has made significant contributions to the field of HIV research, with a focus on the immune response to HIV infection and the effectiveness of antiretroviral therapies. Her work includes studies on T CD4+ recovery post-ART, the correlation of immune activation with HIV-1 proviral DNA, and the regulation of viral proteins for HIV-1 inactivation. She has also explored the impact of antilymphocyte autoantibodies on HIV-1 envelope-dependent membrane fusion and investigated transmitted HIV drug resistance in newly infected individuals.

Aliases

Throughout her academic career, Mónica Viveros-rogel has published under several aliases, including M Viveros-rogel, M Viveros–rogel, and Monica Viveros-rogel.

Publication and Citation Metrics

Metric	Value
Citation Count	53
H-index	4
Paper Count	10

Publications:

Exceptional T CD4+ recovery post-ART is linked to a lower HIV reservoir with a specific immune differentiation pattern.

DOI: 10.1089/AID.2020.0270

Year: 2021

Persistently high levels of immune activation and their correlation with the HIV-1 proviral DNA and 2-LTR circles loads, in a cohort of Mexican individuals following long-term and fully suppressive treatment.

DOI: 10.21203/rs.2.21753/v1

Year: 2020

Regulation of Cas9 by viral proteins Tat and Rev for HIV-1 inactivation.

DOI: 10.1016/j.antiviral.2020.104856

Year: 2020

Persistent high levels of immune activation and their correlation with the HIV-1 proviral DNA and 2-LTR circles loads, in a cohort of Mexican individuals following long-term and fully suppressive treatment.

DOI: 10.1016/j.ijid.2020.08.044

Year: 2020

Inhibition of HIV-1 envelope-dependent membrane fusion by serum antilymphocyte autoantibodies is associated with low plasma viral load.

DOI: 10.1016/j.imlet.2019.05.002

Year: 2019

Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

DOI: 10.7448/IAS.19.6.21264

Year: 2016

HPTN 069/ACTG A5305: phase II study of maraviroc-containing regimens for HIV PrEP in US women; Postive impact of a randomized controlled trial of the Uthando Lwethu ("Our Love") intervention on rates of couples HIV testing in rural South Africa

DOI:

Year: 2016

Program and abstracts for the 2012 Joint Meeting of the Society for Glycobiology & American Society for Matrix Biology

DOI: 10.1093/GLYCOB/CWS127

Year: 2012

Transmitted HIV drug resistance among drug-naive subjects recently infected with HIV in Mexico City: a World Health Organization survey to classify resistance and to field test two alternative patient enrollment methods.

DOI: 10.1093/cid/cir938

Year: 2012

Human immunodeficiency virus 1 (HIV-1) envelope-dependent cell-cell fusion modulation by HIV-positive sera is related to disease progression.

DOI: 10.1099/VIR.0.80635-0

Year: 2005

How Does the Innate Immune System Interact with the Adaptive Immune System?

How Does the Immune System Recognize Pathogens?

What Role Does Epidemiology Play in Outbreaks?

Is Fatigue a Long-term Issue in Infectious Diseases?

What is Veterinary Medicine?

How are Resources Prioritized?

How Do Respiratory Droplets Spread Diseases?

What is Ebola Virus?

What Research is Being Done on Dengue Hemorrhagic Fever?

What Should You Do if You Suspect Contamination?

Partnered Content Networks

Relevant Topics